Creative Medical Technology Holdings, Inc. Increase (Decrease) in Derivative Liabilities
Creative Medical Technology Holdings, Inc. (CELZ) reported Increase (Decrease) in Derivative Liabilities of $0 for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2022-08-12
- Creative Medical Technology Holdings, Inc. increase (decrease) in derivative liabilities for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. increase (decrease) in derivative liabilities for the quarter ending 2022-03-31 was $0.00.
- Creative Medical Technology Holdings, Inc. increase (decrease) in derivative liabilities for the quarter ending 2021-12-31 was $52.06M.
- Creative Medical Technology Holdings, Inc. increase (decrease) in derivative liabilities for the quarter ending 2021-09-30 was $194.04K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in derivative liabilities for fiscal 2021 was $26.03M.
- Creative Medical Technology Holdings, Inc. increase (decrease) in derivative liabilities for fiscal 2020 was -$33.98M.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $52.06M derived: sum of 3 quarters · filed 2022-08-12 | $52.26M derived: sum of 4 quarters · filed 2022-08-12 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $52.06M derived: sum of 2 quarters · filed 2022-05-13 | $52.26M derived: sum of 3 quarters · filed 2022-05-13 | $54.51M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-12-31 | $52.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $52.26M derived: sum of 2 quarters · filed 2022-03-30 | $54.51M derived: sum of 3 quarters · filed 2022-08-12 | $26.03M 10-K · filed 2022-03-30 |
| 2021-09-30 | $194.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $2.45M derived: sum of 2 quarters · filed 2022-08-12 | -$26.03M 10-Q · filed 2021-11-15 | -$56.01M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-06-30 | $2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$26.22M 10-Q · filed 2022-08-12 | -$56.21M derived: sum of 3 quarters · filed 2022-08-12 | -$57.14M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$28.48M 10-Q · filed 2022-05-13 | -$58.46M derived: sum of 2 quarters · filed 2022-05-13 | -$59.39M derived: sum of 3 quarters · filed 2022-05-13 | |
| 2020-12-31 | -$29.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$30.91M derived: sum of 2 quarters · filed 2022-03-30 | -$33.98M 10-K · filed 2022-03-30 | |
| 2020-09-30 | -$926.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$4.00M 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | -$3.07M 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |